Szabolcs I, Kovács Z, Gönczi J, Kákosy T, Góth M, Dohán O, Kovács L, Szilágyi G
1st Department of Medicine, Haynal Imre University of Health Sciences, Budapest, Hungary.
Eur J Endocrinol. 1995 Sep;133(3):294-9. doi: 10.1530/eje.0.1330294.
The aim of this study was to investigate the prevalence of thyroid dysfunction in different geriatric subpopulations from a moderately iodine-deficient Hungarian region and to compare the efficacy of clinical versus hormonal screening. A screening study was done on 279 chronically ill geriatric patients (Group I) and 256 consecutive hospital admissions over 60 years of age (Group II). The method of clinical screening was different from those used so far: the object was not to search for symptoms of hypo- or hyperthyroidism but to find any sign justifying a further thyrotrophin-based biochemical evaluation, i.e. history of thyroid disease or goitre or any clinical sign of hormonal dysfunction. The rates of overt hypothyroidism, overt hyperthyroidism, subclinical hypothyroidism and subclinical hyperthyroidism discovered by the hormonal screening were 2.9, 1.1, 3.6 and 5.7% in Group I and 3.5, 2.3, 3.9 and 2.0% in Group II. The sensitivities of the clinical screening to suspect overt or overt+subclinical dysfunctions were, respectively, 0.82 and 0.64 in Group I and 1.0 and 0.7 in Group II (or 0.67 and 0.4 if the clinical investigation was done not by an endocrinologist but by the medical attendants). A primarily clinical investigation-based screening would have spared 171/279 thyrotrophin estimation in Group I and 161/256 in Group II, but would have missed 2/11 overt and 11/26 subclinical dysfunctions in Group I. In Group II, no overt but 9/15 subclinical dysfunctions would have been lost in this way. Our approach of a clinical investigation-based screening was rather efficient in suspicion of overt thyroid dysfunction but failed to detect many cases with subclinical dysfunction.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究旨在调查匈牙利一个碘中度缺乏地区不同老年亚人群中甲状腺功能障碍的患病率,并比较临床筛查与激素筛查的效果。对279例慢性病老年患者(第一组)和256例60岁以上连续入院患者(第二组)进行了筛查研究。临床筛查方法与以往不同:目的不是寻找甲状腺功能减退或亢进的症状,而是寻找任何有理由进行进一步促甲状腺素生化评估的体征,即甲状腺疾病或甲状腺肿病史或激素功能障碍的任何临床体征。激素筛查发现的显性甲状腺功能减退、显性甲状腺功能亢进、亚临床甲状腺功能减退和亚临床甲状腺功能亢进的发生率在第一组分别为2.9%、1.1%、3.6%和5.7%,在第二组分别为3.5%、2.3%、3.9%和2.0%。临床筛查怀疑显性或显性+亚临床功能障碍的敏感性在第一组分别为0.82和0.64,在第二组分别为1.0和0.7(如果临床检查不是由内分泌学家而是由医护人员进行,则为0.67和0.4)。基于初步临床检查的筛查在第一组可避免279例中的171例促甲状腺素检测,在第二组可避免256例中的161例,但会漏诊第一组2/11的显性和11/26的亚临床功能障碍。在第二组中,这样会漏诊9/15的亚临床功能障碍,但不会漏诊显性功能障碍。我们基于临床检查的筛查方法在怀疑显性甲状腺功能障碍方面相当有效,但未能检测出许多亚临床功能障碍病例。(摘要截选至250字)